Activity of "NO-donor" or "NO-mediated" drugs

Monaldi Archives for Chest Disease

Volumn 56, Issue 1, 2001, Pages 95-98

  Morbidelli, L ^a   Donnini, S ^a   Ziche, M ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Drugs; Nitro derivatives; Vasculature

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRO DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHODIESTERASE; S NITROSOCAPTOPRIL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; CELL COMMUNICATION; CELL FUNCTION; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; SIGNAL TRANSDUCTION;

EID: 0034996902     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Feelisch M. - The use of nitric oxide donors in pharmacological studies, Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 113-122.
2. Hou YC, Janezuk A. Wang PG. - Current trends in the development of nitric oxide donors. Curr Pharm Des 1999; 5: 417-441.
3. Al-Sa'doni H, Ferro A. - S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci 2000; 98; 507-520.
4. Del Soldato P, Sorrentino R, Pinto A. - NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. TiPS 1999; 20: 319-323
5. Colasanti M, Suzuki H. - The dual personality of NO. Trends Pharmacol Sci 1999; 21: 249-252.
6. Jia L, Blantz RC. - The effects of s-nitrosocaptopril on renal filtration and blood pressure in rats. Eur J Pharmacol 1998; 354: 33-41.
7. Patel JM, Martens JR. Li YD, Gelband CH, Raizada MK, Block ER. - Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am J Physiol 1998; 275. L1061-1068.
8. De Nucci G. Thomas R, D'Orleans-Juste P, et al. - Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800.
9. Ziche M, Morbidelli L, Masini E, et al. - Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036-2044.
10. Morbidelli L, Parenti A, Donnini S, Granger HJ, Ledda F, Ziche M. - Differential contribution of bradykinin receptors in angiogenesis. Adv Exp Med Biol 2000; 476: 117-128.
11. Morbidelli L, Parenti A, Giovannelli L, Granger HJ, Ledda F, Ziche M. - B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects. Br J Pharmacol 1998; 124: 1286-1292.
12. Parenti A, Filippi S, Amerini S, Granger HJ, Fazzini A, Ledda F. - Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol. J Pharmacol Exp Ther 2000; 292: 698-703.
13. Van Belle E, Vallet B, Auffray JL, et al. - NO synthesis is involved in the structural and functional effects of ACE inhibitors in injured arteries. Am J Physiol 1996; 270: H298-305.
14. Ziche M, Morbidelli L, Choudhuri R, et al. - Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-2634.
15. Ziche M, Morbidelli L, Masini E, Granger H, Geppetti P, Ledda F. - Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from post-capillary venules. Biochem Biophys Res Commun 1993; 192: 1198-1203.
16. Kureishi Y, Luo Z, Shiojima I, et al. - The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004-1010.
17. Jeffery TK, Wanstall JC. - Phosphodiesterase III and V inhibitors on pulmonary artery from pulmonary hypertensive rats: differences between early and established pulmonary hypertension. J Cardiovasc Pharmacol 1998; 32: 213-219.
18. Gaballa MA, Goldman S. - Gene transfer of endothelial nitric oxide isoform decreases rat hindlimb vascular resistance in vivo. Hum Gene Ther 2000; 11: 1637-1646.
19. Kader KN, Akella R, Ziats NP, et al. - eNOS-over-expressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng 2000; 6: 241-251.